LataMed AI Proposes 5-for-1 Forward Stock Split to Boost Liquidity, Support Growth
LMED has more than doubled off its 52-week low of $0.265 on light trading volume (0.2× avg).
Summary
LataMed AI Corp. (LMED) announced its intent to submit a request to FINRA for a five-for-one (5-for-1) forward stock split, along with proportional increases in authorized common and preferred stock. This corporate action is intended to support broader long-term operational scalability, strategic flexibility, capitalization planning, and future growth initiatives as the company advances its telehealth infrastructure and AI-driven healthcare operations in emerging markets. While a stock split does not change the company's fundamental valuation, it will increase the number of outstanding shares and reduce the per-share price, potentially enhancing liquidity and making the stock more accessible to a wider range of investors, which can be particularly beneficial for an OTC-listed company. Traders should monitor FINRA's approval process and the effective date of the split.
At the time of this announcement, LMED was trading at $2.53 on OTC in the Technology sector, with a market capitalization of approximately $142M. The 52-week trading range was $0.27 to $2,025.02. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: EQS.